GLP3, GLP5, and Retatrutide–Cagrilintide: Do Vendor Names Describe One Molecule or a Two-Compound Blend?

As the research chemical landscape evolves with next-generation multi-receptor agonists, vendor naming conventions have become increasingly confusing. Researchers, clinic owners, and buyers browsing peptide catalogs frequently encounter terms like "GLP3," "GLP5," or "the 4-receptor stack."

The core question for many professionals is: Do these names represent newly discovered single molecules, or are they simply vendor shorthand for custom peptide blends?

The short answer: There is no such thing as a "GLP-3" or "GLP-5" receptor in human biology. These terms are marketing aliases. "GLP3" is widely used by vendors to describe Retatrutide, a single molecule that agonizes three distinct receptors. "GLP5," on the other hand, describes a two-compound blend packed into one vial—specifically, a stack of Retatrutide and Cagrilintide.

Here is a definitive breakdown of what these terms mean, how the compounds interact, and how to source verified research chemicals for your laboratory or clinic.

What is "GLP3"? Understanding Retatrutide

When you see a vial labeled "GLP3," the vendor is almost certainly selling Retatrutide.

Retatrutide is a single, structurally unified peptide molecule. It is engineered to be a tri-agonist, meaning it simultaneously binds to and activates three different receptors:

1. GLP-1 (Glucagon-like peptide-1)
2. GIP (Glucose-dependent insulinotropic polypeptide)
3. GCGR (Glucagon receptor)

Because it targets three metabolic pathways, vendors adopted "GLP3" as an easy-to-remember shorthand. However, scientifically, it is simply Retatrutide. As a next-gen multi-receptor agonist, it is currently one of the most heavily researched compounds in metabolic and weight management studies.

Explore our high-purity single-molecule compound: Retatrutide Research Vials

What is "GLP5"? The Retatrutide and Cagrilintide Blend

If "GLP3" refers to a three-receptor agonist, what is "GLP5"?

"GLP5" is a vendor-created marketing name for a two-compound blend housed in a single vial, most commonly Retatrutide + Cagrilintide. It is not a new, five-receptor molecule.

Here is how the math behind the marketing name works:

• Retatrutide hits 3 receptors (GLP-1, GIP, Glucagon).
• Cagrilintide is a long-acting amylin analog that targets the calcitonin/amylin receptor pathways.
• Vendors combine the synergistic effects of these two separate molecules and label the resulting stack as "GLP5" or the "LEAN blend."

While Cagrilintide is often studied alongside GLP-1s to observe compounded metabolic pacing and gastric emptying effects, researchers must note that a fixed Retatrutide + Cagrilintide blend currently lacks formal human trial data as a combined entity. It is strictly a research stack.

Explore the components: Cagrilintide | Custom Formulas

Comparison: Single Molecule vs. Two-Compound Blend

For quick reference, here is the technical distinction between the entities often mislabeled in the market:

Beyond Metabolic Blends: Advancing Your Research Stack

Many advanced clinics and private researchers are expanding their focus beyond foundational metabolic multi-receptor agonists. Incorporating mitochondrial optimization and cellular energy research is becoming a standard practice.

At Evorpep, researchers frequently study metabolic pathways in conjunction with energy-boosting and anti-aging compounds, including:

• MOTS-c – A mitochondrial-derived peptide for metabolic homeostasis.
• SS-31 (Elamipretide) – Targets inner mitochondrial membrane health.
• NAD+ – Essential for cellular energy transfer and longevity protocols.

View our complete range of research chemicals: Full Catalog

Quality Control: Why Sourcing Matters for Peptide Blends

When dealing with mixed compounds like a Retatrutide-Cagrilintide blend, purity testing becomes exponentially more complex. Substandard vendors may suffer from cross-contamination, inaccurate mixing ratios, or degraded peptides.

As a leader in Next-Gen Multi-Receptor Agonist Research Chemicals, Evorpep guarantees rigorous Quality Control. We utilize advanced analytical laboratories to ensure every batch meets stringent purity requirements.

• Verify Batch Purity: Access our transparent testing results on the Verify COA page.
• Custom Synthesis: Need a specific ratio for your clinical research? Explore our Custom Peptide Synthesis services.
• B2B & Wholesale: We support clinics, salons, and resellers with scalable Wholesale & Private Label solutions.

Ready to advance your research?

• 📩 Request a Custom Quote
• 💬 Speak with Sales via Live Chat
• 📞 Contact the Evorpep Team